Misdiagnosis and Chemotherapy Delaying Reduces the Chemosensitivity of Choriocarcinoma Patient: Analysis of 36 Cases
Background: Choriocarcinoma is a curable malignant neoplasm when chemotherapy is properly implemented. However, when chemotherapy resistance occurs, disease can be fatal. Misdiagnosis is common, which may lead to delaying of the first cycle of chemotherapy and increase the possibility of chemoresist...
Main Authors: | Lin-Jing Yuan, Yu-Ying Chen, Cai-Xia Zhu, Yi-Zi Wang, Guo-Fen Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
IMR Press
2022-07-01
|
Series: | Clinical and Experimental Obstetrics & Gynecology |
Subjects: | |
Online Access: | https://www.imrpress.com/journal/CEOG/49/8/10.31083/j.ceog4908179 |
Similar Items
-
Mechanisms Underlying Chemoresistance of Choriocarcinoma Investigated with NMR-Based Metabonomics
by: DING Lai-feng, et al.
Published: (2019-12-01) -
Pure Non-Gestational Choriocarcinoma: A Case Report
by: Helena Azimi, et al.
Published: (2023-12-01) -
Adjuvant chemotherapy of resistant high risk choriocarcinoma
by: Đuričić Tamara, et al.
Published: (2021-01-01) -
PROGNOSIS OF GESTATIONAL CHORIOCARCINOMA – 8 -YEAR EXPERIENCE
by: Biljana Lazović, et al.
Published: (2012-06-01) -
Primary Nongestational Choriocarcinoma of the Ovary
by: AMM Shariful Alam, et al.
Published: (2014-01-01)